Role of the ovary in the adrenal androgen excess of hyperandrogenic women.

[1]  R. Lobo,et al.  Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome. , 1996, Fertility and sterility.

[2]  R. Rittmaster,et al.  Dose-response effect of depot leuprolide acetate on serum androgens in hirsute women. , 1996, Fertility and sterility.

[3]  R. Azziz,et al.  Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. , 1995, The Journal of clinical endocrinology and metabolism.

[4]  R. Lobo,et al.  Reassessment of Adrenal Androgen Secretion in Women With Polycystic Ovary Syndrome , 1995, Obstetrics and gynecology.

[5]  R. Azziz,et al.  Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. , 1995, American journal of obstetrics and gynecology.

[6]  D. de Lorenzo,et al.  Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome. , 1995, Fertility and sterility.

[7]  R. Lobo,et al.  The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome. , 1995, The Journal of clinical endocrinology and metabolism.

[8]  H. Escobar-Morreale,et al.  Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha. , 1994, Fertility and sterility.

[9]  R. Azziz,et al.  ∆5-Androstene-3β,17β-diol in healthy eumenorrheic women: relationship to body mass and hormonal profile * † , 1994 .

[10]  R. Rittmaster.  Androgen conjugates: physiology and clinical significance. , 1993, Endocrine reviews.

[11]  R. Lobo,et al.  Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? , 1992, American journal of obstetrics and gynecology.

[12]  D. de Ziegler,et al.  Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction. , 1992, Fertility and sterility.

[13]  R. Lobo,et al.  Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate? , 1991, American journal of obstetrics and gynecology.

[14]  L. Speroff,et al.  Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. , 1991, American journal of obstetrics and gynecology.

[15]  R. Azziz,et al.  The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women. , 1991, The Journal of clinical endocrinology and metabolism.

[16]  D. Thompson,et al.  Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. , 1990, The Journal of clinical endocrinology and metabolism.

[17]  R. Azziz,et al.  21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. , 1989, The Journal of clinical endocrinology and metabolism.

[18]  R. Rittmaster.  Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide. , 1988, The Journal of clinical endocrinology and metabolism.

[19]  E. Carmina,et al.  Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients , 1986, Journal of endocrinological investigation.

[20]  R. Lobo,et al.  The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. , 1984, Fertility and sterility.

[21]  R. Wild,et al.  Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. , 1983, American journal of obstetrics and gynecology.

[22]  W. Vale,et al.  Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. , 1983, The Journal of clinical endocrinology and metabolism.

[23]  M. Kim,et al.  Hirsutism: implications, etiology, and management. , 1981, American journal of obstetrics and gynecology.

[24]  G. Strain,et al.  Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. , 1980, The Journal of clinical endocrinology and metabolism.

[25]  B. Murphy.  Methodological problems in competitive protein-binding techniques; the use of sephadex column chromatography to separate steroids. , 1970, Acta endocrinologica. Supplementum.

[26]  W. H. Pearlman,et al.  Steroid-protein interaction with particular reference to testosterone binding by human serum. , 1967, The Journal of biological chemistry.

[27]  C. Castelo-Branco,et al.  Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism. , 1996, Metabolism: clinical and experimental.